Cargando…

Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Vitiello, Antonio, Ferrara, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055751/ https://www.ncbi.nlm.nih.gov/pubmed/33877436 http://dx.doi.org/10.1007/s00508-021-01855-6

Ejemplares similares

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021)

The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
por: Vitiello, Antonio, et al.
Publicado: (2020)

Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute?
por: Doumas, Michael, et al.
Publicado: (2020)

Effects of Vitamin D on the Renin–Angiotensin System and Acute Childhood Pneumonia
por: Zovi, Andrea, et al.
Publicado: (2022)

The extended renin-angiotensin system: a promising target for traumatic brain injury therapeutics
por: Janatpour, Zachary C., et al.
Publicado: (2019)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
por: Kang, Si-Hyuck, et al.
Publicado: (2021)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

The systemic renin-angiotensin system in COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
por: Edenfield, R. Clayton, et al.
Publicado: (2021)

Renin-angiotensin system at the heart of COVID-19 pandemic
por: Alifano, Marco, et al.
Publicado: (2020)

Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19
por: Vitiello, A., et al.
Publicado: (2020)

Amelioration of Hypertension by Oryeongsan through Improvements of Body Fluid and Sodium Balance: Roles of the Renin-Angiotensin System and Atrial Natriuretic Peptide System
por: Ahn, You Mee, et al.
Publicado: (2022)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
por: Atlas, Steven A.
Publicado: (2007)

The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
por: Lumbers, Eugenie R., et al.
Publicado: (2022)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Cardiovascular effects of small peptides of the renin angiotensin system
por: Moraes, Patrícia L., et al.
Publicado: (2017)

Pharmacological Agents with Antiviral Activity against Monkeypox Infection
por: Zovi, Andrea, et al.
Publicado: (2022)

Renin-angiotensin system at the interface of COVID-19 infection
por: Gul, Rukhsana, et al.
Publicado: (2021)

Renin-angiotensin system inhibition in COVID-19 patients
por: de Vries, A. A. F.
Publicado: (2020)

COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
por: Amraei, Razie, et al.
Publicado: (2020)

Covid-19: the renin–angiotensin system imbalance hypothesis
por: Lanza, Katharina, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

Renin–Angiotensin System Implications to COVID-19 Comorbidities
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Quantifying Renin-Angiotensin-System Alterations in COVID-19
por: Pucci, Fabrizio, et al.
Publicado: (2021)

Renin Angiotensin System Inhibition as treatment for Covid-19?
por: Williams, Professor Bryan
Publicado: (2021)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2sngptvmfeqb37ckinsd7ik9sl